These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 26283707)

  • 1. Cell signaling pathways involved in drug-mediated fetal hemoglobin induction: Strategies to treat sickle cell disease.
    Pace BS; Liu L; Li B; Makala LH
    Exp Biol Med (Maywood); 2015 Aug; 240(8):1050-64. PubMed ID: 26283707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding mechanisms of gamma-globin gene regulation to develop strategies for pharmacological fetal hemoglobin induction.
    Pace BS; Zein S
    Dev Dyn; 2006 Jul; 235(7):1727-37. PubMed ID: 16607652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders.
    Perrine SP; Ginder GD; Faller DV; Dover GH; Ikuta T; Witkowska HE; Cai SP; Vichinsky EP; Olivieri NF
    N Engl J Med; 1993 Jan; 328(2):81-6. PubMed ID: 7677966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Butyrate derivatives. New agents for stimulating fetal globin production in the beta-globin disorders.
    Perrine SP; Olivieri NF; Faller DV; Vichinsky EP; Dover GJ; Ginder GD
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):67-71. PubMed ID: 7508690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future prospects for treatment of hemoglobinopathies.
    Stamatoyannopoulos JA
    West J Med; 1992 Dec; 157(6):631-6. PubMed ID: 1282285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting fetal hemoglobin expression to treat β hemoglobinopathies.
    Steinberg MH
    Expert Opin Ther Targets; 2022 Apr; 26(4):347-359. PubMed ID: 35418266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted fetal hemoglobin induction for treatment of beta hemoglobinopathies.
    Perrine SP; Pace BS; Faller DV
    Hematol Oncol Clin North Am; 2014 Apr; 28(2):233-48. PubMed ID: 24589264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple physical stresses induce γ-globin gene expression and fetal hemoglobin production in erythroid cells.
    Schaeffer EK; West RJ; Conine SJ; Lowrey CH
    Blood Cells Mol Dis; 2014 Apr; 52(4):214-24. PubMed ID: 24314748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiourea derivatives induce fetal hemoglobin production in-vitro: A new class of potential therapeutic agents for β-thalassemia.
    Ali H; Iftikhar F; Shafi S; Siddiqui H; Khan IA; Choudhary MI; Musharraf SG
    Eur J Pharmacol; 2019 Jul; 855():285-293. PubMed ID: 31100414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Rapamycin as Inducer of Hb F in Primary Erythroid Cultures from Sickle Cell Disease and β-Thalassemia Patients.
    Pecoraro A; Troia A; Calzolari R; Scazzone C; Rigano P; Martorana A; Sacco M; Maggio A; Di Marzo R
    Hemoglobin; 2015; 39(4):225-9. PubMed ID: 26016899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of NRF2 activation to mediate fetal hemoglobin induction and protection against oxidative stress in sickle cell disease.
    Zhu X; Oseghale AR; Nicole LH; Li B; Pace BS
    Exp Biol Med (Maywood); 2019 Feb; 244(2):171-182. PubMed ID: 30674214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological induction of fetal hemoglobin in sickle cell disease and beta-thalassemia.
    Atweh GF; Loukopoulos D
    Semin Hematol; 2001 Oct; 38(4):367-73. PubMed ID: 11605172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Novel Fetal Hemoglobin Inducers through Small Chemical Library Screening.
    Breveglieri G; Pacifico S; Zuccato C; Cosenza LC; Sultan S; D'Aversa E; Gambari R; Preti D; Trapella C; Guerrini R; Borgatti M
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33050052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular biology of hemoglobin: its application to sickle cell anemia and thalassemia.
    Kan YW
    Schweiz Med Wochenschr Suppl; 1991; 43():51-4. PubMed ID: 1726857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of fetal hemoglobin as a novel therapeutic strategy for β-hemoglobinopathy.
    Fard AD; Kaviani S; Noruzinia M; Saki N; Mortaz E
    Lab Hematol; 2014 Mar; 20(1):1. PubMed ID: 24694782
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological induction of fetal hemoglobin synthesis using histone deacetylase inhibitors.
    Cao H
    Hematology; 2004 Jun; 9(3):223-33. PubMed ID: 15204104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent and orally active purine-based fetal hemoglobin inducers for treating β-thalassemia and sickle cell disease.
    Lai ZS; Yeh TK; Chou YC; Hsu T; Lu CT; Kung FC; Hsieh MY; Lin CH; Chen CT; James Shen CK; Jiaang WT
    Eur J Med Chem; 2021 Jan; 209():112938. PubMed ID: 33109398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended therapy with intravenous arginine butyrate in patients with beta-hemoglobinopathies.
    Sher GD; Ginder GD; Little J; Yang S; Dover GJ; Olivieri NF
    N Engl J Med; 1995 Jun; 332(24):1606-10. PubMed ID: 7753139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
    Rodgers GP; Dover GJ; Uyesaka N; Noguchi CT; Schechter AN; Nienhuis AW
    N Engl J Med; 1993 Jan; 328(2):73-80. PubMed ID: 7677965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When basic science reaches into rational therapeutic design: from historical to novel leads for the treatment of β-globinopathies.
    Andrieu-Soler C; Soler E
    Curr Opin Hematol; 2020 May; 27(3):141-148. PubMed ID: 32167946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.